Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment

Completed · Not applicable

Conditions studied: Migraine Disorders

In brief

This study tests the effect of a new behavioral intervention, Emotional Awareness and Expression Therapy (EAET), as a possible new treatment for people living with migraine. The main questions it aims to answer are: Can EAET lower the frequency and severity of migraine attacks? What are the elements that can explain EAET's effect? Requirements from Participants: Participants will be randomized into either a treatment or control arms. Those who are assigned to the control arm are eligible to receive the treatment in the next cohort. Participants assigned to the treatment arms are expected to engage in 8 weekly online sessions via Zoom (sessions are 2 hours long). Each session has a lecture, in-class exercises, discussion, and weekly assignments. Each participant is required to fill out questionnaires before the first session, and after the last session of the treatment. Participants will benefit from a new and promising intervention that can significantly help with their migraines at no cost.

Key facts

Study ID

NCT05837650

Run by

University of Utah

People needed

30

Starts

2023-04-01

Expected to finish

2025-03-31

Last updated by the study team

2025-11-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults of all genders, ages 18-80.
• A diagnosis of either episodic or chronic migraine (with or without aura) by a licensed neurologist.
• A migraine disability assessment scores higher than 6.
• A stable medication regimen for a minimum of 3 months.
• Must have had migraines for at least 1 year.
• Must have a minimum of 4 migraine days per month.

You may not qualify if…

• Serious psychiatric disorders (e.g., schizophrenia or bipolar disorder) uncontrolled with medications.
• Active suicidal ideation.
• Risk of violent behavior.
• Untreated alcohol or substance use disorder.
• Substantial cognitive impairment.
• A diagnosis of medication overuse headaches.
• Changes in migraine medication in the past 3 months.
• Enrollment in another treatment study.
• Current involvement in health-related litigation or disability application.
• Inability to use a computer and/or smartphone.
• limited access to the internet.
• Inability to communicate in English.
• Failure to complete at least 85% of the daily diaries during the baseline 30-day diary assessment.

Where it is running

• Dan Kaufmann — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.